Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Licata, Stephanie C ^a,b   Shinday, Nina M ^b   Huizenga, Megan N ^b,c   Darnell, Shayna B ^b,c   Sangrey, Gavin R ^b,c   Rudolph, Uwe ^a,b   Rowlett, James K ^b   Sadri Vakili, Ghazaleh ^b,c  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIAZEPAM; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; PROTEIN C FOS; TRIAZOLAM; ZOLPIDEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BDNF GENE; BRAIN LEVEL; CONTROLLED STUDY; DOWN REGULATION; DRUG PROTEIN BINDING; DRUG TARGETING; EXPERIMENTAL MOUSE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCATION; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PHARMACOGENETICS; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; BENZODIAZEPINES; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHROMATIN IMMUNOPRECIPITATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIAZEPAM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-FOS; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIAZOLAM;

EID: 84893203201     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084806     Document Type: Article

References (82)

1. Tallman JF, Thomas JW, Gallager DW (1978) GABAergic modulation of benzodiazepine binding site sensitivity. Nature 274: 383-385. doi:10.1038/274383a0. PubMed: 27722.
2. A receptor modulation and beyond. Pharmacology Biochemistry, and Behavior 90: 74-89. doi:10.1016/j.pbb.2008.01. 001.
3. Stewart SA (2005) The effects of benzodiazepines on cognition. J Clin Psychiatry 66 [suppl 2]: 9-13. PubMed: 15762814.
4. Licata SC, Nickerson LD, Lowen SB, Trksak GH, MacLean RR et al. (2013) The hypnotic zolpidem increases the synchrony of BOLD signal fluctuations in widespread brain networks during a resting paradigm. NeuroImage 70: 211-222. doi:10.1016/j.neuroimage.2012.12.055. PubMed: 23296183.
5. Rudolph U, Möhler H (2006) GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr Opin Pharmacol 6: 18-23. doi:10.1016/j.coph. 2005.10.003. PubMed: 16376150.
6. A receptor-specific expression profiling. J Neurochem 88: 1059-1067. doi:10.1046/j.1471-4159.2003.02216.x. PubMed: 15009662.
7. Kim DH, Kim S, Jeon SJ, Son KH, Lee S et al. (2009) Tanshinone I enhances learning and memory, and ameliorates memory impairment in mice via the extracellular signal-regulated kinase signaling pathway. Br J Pharmacol 158: 1131-1142. doi:10.1111/j.1476-5381.2009.00378.x. PubMed: 19775283.
8. Saraf MK, Prabhakar S, Pandhi P, Anand A (2008) Bacopa monniera ameliorates amnesic effects of diazepam qualifying behavioral-molecular partitioning. Neuroscience 155: 476-484. doi:10.1016/j.neuroscience.2008.05.043. PubMed: 18585439.
9. Bozas E, Tritos N, Phillipidis H, Stylianopoulou F (1997) At least three neurotransmitter systems mediate a stress-induced increase in c-fos mRNA in different rat brain areas. Cell Mol Neurobiol 17: 157-169. doi:10.1023/A: 1026309727518. PubMed: 9140695.
10. Fukuda K, Shoda T, Mima H, Uga H (2002) Midazolam induces expression of c-Fos and EGR-1 by a non-gabaergic mechanism. Anesth Analg 95: 373-378. PubMed: 12145054.
11. Malkani S, Rosen JB (2000) Differential expression of EGR-1 mRNA in the amygdala following diazepam in contextual fear conditioning. Brain Res 860: 53-63. doi:10.1016/S0006-8993(00)01976-4. PubMed: 10727623.
12. Niles LP, Smith LJ, Tenn CC (1997) Modulation of c-fos expression in the rat striatum by diazepam. Neurosci Lett 236: 5-8. doi:10.1016/S0304-3940(97) 00755-6. PubMed: 9404938.
13. Salminen O, Lahtinen S, Ahtee L (1996) Expression of Fos protein in various rat brain areas following acute nicotine and diazepam. Pharmacol Biochem Behav 54: 241-248. doi:10.1016/0091-3057(95)02132-9. PubMed: 8728564.
14. Thompson BL, Rosen JB (2006) Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs. Neuropharmacology 50: 57- 68. doi:10.1016/j.neuropharm.2005.07.024. PubMed: 16185722.
15. Huang TL, Hung YY (2009) Lorazepam reduces the serum brain-derived neurotrophic factor level in schizophrenia patients with catatonia. Progress in Neuropsychopharmacol and Biological Psychiatry 33: 159-159.
16. Kellogg CK, Yao J, Pleger GL (2000) Sex-specific effects of in utero manipulation of GABA(A) receptors on pre- and postnatal expression of BDNF in rats. Brain Research. Developmental Brain Research 121: 157-167. doi:10.1016/S0165-3806(00)00039-0. PubMed: 10876028.
17. Zafra F, Castrén E, Thoenen H, Lindholm D (1991) Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci U S A 88: 10037-10041. doi:10.1073/pnas.88.22.10037. PubMed: 1658793.
18. Balu DT, Hoshaw BA, Malberg JE, Rosenzweig-Lipson S, Schechter LE et al. (2008) Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res 1211: 37-43. doi:10.1016/j.brainres.2008.03.023. PubMed: 18433734.
19. Guzowski JF (2002) Insights into immediate-early gene function in hippocampal memory consolidation using antisense oligonucleotide and fluorescent imaging approaches. Hippocampus 12: 86-104. doi:10.1002/hipo.10010.abs. PubMed: 11918292.
20. Lu B, Chow A (1999) Neurotrophins and hippocampal synaptic transmission and plasticity. J Neurosci Res 58: 76-87. doi:10.1002/(SICI)1097-4547(19991001) 58:1. PubMed: 10491573.
21. Chang SL, Squinto SP, Harlan RE (1988) Morphine activation of c-fos expression in rat brain. Biochem Biophys Res Commun 157: 698-704. doi:10.1016/S0006-291X(88)80306-1. PubMed: 3144275.
22. Marie-Claire C, Laurendeau I, Canestrelli C, Courtin C, Vidaud M et al. (2003) Fos but not Cart (cocaine and amphetamine regulated transcript) is overexpressed by several drugs of abuse: a comparative study using real-time quantitative polymerase chain reaction in rat brain. Neurosci Lett 345: 77-80. doi:10.1016/S0304-3940(03)00307-0. PubMed: 12821175.
23. Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56 Suppl 1: 73-82. doi:10.1016/j.neuropharm.2008.06.059. PubMed: 18647613.
24. Eisch AJ, Harburg GC (2006) Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology. Hippocampus 16: 271-286. doi:10.1002/hipo.20161. PubMed: 16411230.
25. Sanger DJ, Joly D, Zivkovic B (1986) Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice. Psychopharmacology (Berl) 90: 207-210. PubMed: 2878460.
26. Benavides J, Peny B, Dubois A, Perrault G, Morel E et al. (1988) In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype. J Pharmacol Exp Ther 245: 1033-1041. PubMed: 2838599.
27. Elliott EE, White JM (2000) Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem. Pharmacology Biochemistry, and Behavior 66: 361-369. doi:10.1016/S0091-3057(00)00176-3.
28. van Rijnsoever C, Täuber M, Choulli MK, Keist R, Rudolph U et al. (2004) Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 24: 6785-6790. doi:10.1523/JNEUROSCI.1067-04.2004. PubMed: 15282283.
29. Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P et al. (2007) Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum Mol Genet 16: 1293-1306. doi:10.1093/hmg/ddm078. PubMed: 17409194.
30. Sadri-Vakili G, Kumaresan V, Schmidt HD, Famous KR, Chawla P et al. (2010) Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci 30: 11735-11744. doi:10.1523/JNEUROSCI.2328-10.2010. PubMed: 20810894.
31. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85: 525-535. doi:10.1002/jnr.21139. PubMed: 17149751.
32. Schmidt HD, Sangrey GR, Darnell SB, Schassburger RL, Cha JH et al. (2012) Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem 120: 202-209. doi:10.1111/j.1471-4159.2011.07571.x. PubMed: 22043863.
33. Braveman MW, Chen-Plotkin AS, Yohrling GJ, Cha JH (2004) Chromatin immunoprecipitation technique for study of transcriptional dysregulation in intact mouse brain. Methods Mol Biol 277: 261-276. PubMed: 15201461.
34. Chen-Plotkin AS, Sadri-Vakili G, Yohrling GJ, Braveman MW, Benn CL et al. (2006) Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. Neurobiol Dis 22: 233-241. doi:10.1016/j.nbd.2005.11.001. PubMed: 16442295.
35. Chen WG, Chang Q, Lin Y, Meissner A, West AE et al. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302: 885-889. doi:10.1126/science.1086446. PubMed: 14593183.
36. Jiang X, Tian F, Du Y, Copeland NG, Jenkins NA et al. (2008) BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability. J Neurosci 28: 1118-1130. doi:10.1523/JNEUROSCI.2262-07.2008. PubMed: 18234890.
37. Martinowich K, Hattori D, Wu H, Fouse S, He F et al. (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302: 890-893. doi:10.1126/science.1090842. PubMed: 14593184.
38. Pritchett DB, Seeburg PH (1991) Gamma-aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepine site. Proc Natl Acad Sci U S A 88: 1421-1425. doi:10.1073/pnas.88.4.1421. PubMed: 1847522.
39. Wieland HA, Lüddens H, Seeburg PH (1992) A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J Biol Chem 267: 1426-1429. PubMed: 1346133.
40. Hadingham KL, Wingrove P, Le Bourdelles B, Palmer KJ, Ragan CI, et al. (1993) Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors. Molecular Pharmacology 43: 970-975.
41. A receptor subtypes. Eur J Pharmacol 451: 103-110. doi:10.1016/S0014-2999(02) 02191-X. PubMed: 12231378.
42. Liu QR, Lu L, Zhu XG, Gong JP, Shaham Y et al. (2006) Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res 1067: 1-12. doi:10.1016/j.brainres.2005.10.004. PubMed: 16376315.
43. Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, Saarma M, Persson H (1993) Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10: 475-489. doi:10.1016/0896-6273(93)90335-O. PubMed: 8461137.
44. West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM et al. (2001) Calcium regulation of neuronal gene expression. Proceedings of the National Academy of Sciences U-S-A 98: 11024-11031. doi:10.1073/pnas.191352298.
45. Alme MN, Wibrand K, Dagestad G, Bramham CR (2007) Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plast: 26496: 26496. PubMed: 18301726.
46. McGinty JF, Whitfield TW Jr, Berglind WJ (2010) Brain-derived neurotrophic factor and cocaine addiction. Brain Res 1314: 183-193. doi:10.1016/j.brainres.2009.08.078. PubMed: 19732758.
47. Xu H, Chen Z, He J, Haimanot S, Li X et al. (2006) Synergistic effects of quetiapine and venlaxafine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 16: 551-559. doi:10.1002/hipo.20184. PubMed: 16652337.
48. Mintzer MZ, Griffiths RR (1999) Triazolam and zolpidem: effects on human memory and attentional processes. Psychopharmacology (Berl) 144: 8-19. doi:10.1007/s002130050971. PubMed: 10379619.
49. del Cerro S, Jung M, Lynch G (1992) Benzodiazepines block long-term potentiation in slices of hippocampus and piriform cortex. Neuroscience 49: 1-6. doi:10.1016/0306-4522(92)90071-9. PubMed: 1407540.
50. Maubach KA, Martin K, Choudhury HI, Seabrook GR (2004) Triazolam suppresses the inductin of hippocampal long-term potentiation. Neuroreport 15: 1145-1149. doi:10.1097/00001756-200405190-00013. PubMed: 15129163.
51. Mori K, Togashi H, Kojima T, Matsumoto M, Ohashi S et al. (2001) Different effects of anxiolytic agents, diazepam and 5-HT(1A) agonist tandospirone, on hippocampal long-term potentiation in vivo. Pharmacol Biochem Behav 69: 367-372. doi:10.1016/S0091-3057(01)00546-9. PubMed: 11509193.
52. Xu JY, Sastry BR (2005) Benzodiazepine involvement in LTP of the GABA-ergic IPSC in rat hippocampal CA1 neurons. Brain Res 1062: 134-143. doi:10.1016/j.brainres.2005.09.008. PubMed: 16266690.
53. Oliveira DR, Sanada PF, Saragossa Filho AC, Innocenti LR, Oler G et al. (2009) Neuromodulatory property of standardized extract Ginkgo biloba L. (EGb 761) on memory: behavioral and molecular evidence. Brain Res 1269: 68-89. doi:10.1016/j.brainres.2008.11.105. PubMed: 19146837.
54. Balkin TJ, O'Donnell VM, Wesensten N, McCann U, Belenky G (1992) Comparison of the daytime sleep and performance effects of zolpidem versus triazolam. Psychopharmacology (Berl) 107: 83-88. doi:10.1007/BF02244970. PubMed: 1589566.
55. Evans SM, Funderburk FR, Griffiths RR (1990) Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 255: 1246-1255. PubMed: 2262904.
56. Higashima M, Kinoshita H, Koshino Y (1998) Differences in the effects of zolpidem and diazepam on recurrent inhibition and long-term potentiation in rat hippocampal slices. Neurosci Lett 245: 77-80. doi:10.1016/S0304-3940(98)00178-5. PubMed: 9605489.
57. A receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101: 815-850. doi:10.1016/S0306-4522(00)00442- 5. PubMed: 11113332.
58. Sperk G, Schwarzer C, Tsunashima K, Fuchs K, Sieghart W (1997) GABA(A) receptor subunits in the rat hippocampus I: immunocytochemical distribution of 13 subunits. Neuroscience 80: 987-1000. doi:10.1016/S0306-4522(97)00146-2. PubMed: 9284055.
59. Fuchikami M, Morinobu S, Kurata A, Yamamoto S, Yamawaki S (2009) Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. Int J Neuropsychopharmacol 12: 73-82. doi:10.1017/S1461145708008997. PubMed: 18544182.
60. Schaaf MJ, de Jong J, de Kloet ER, Vreugdenhil E (1998) Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res 813: 112-120. doi:10.1016/S0006-8993(98)01010-5. PubMed: 9824681.
61. Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15: 1768-1777. PubMed: 7891134.
62. Fuchikami M, Yamamoto S, Morinobu S, Takei S, Yamawaki S (2010) Epigenetic regulation of BDNF gene in response to stress. Psychiatry Investig 7: 251-256. doi:10.4306/pi.2010.7.4.251. PubMed: 21253408.
63. Mikkelsen JD, Søderman A, Kiss A, Mirza N (2005) Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis. Eur J Pharmacol 519: 223-230. doi:10.1016/j.ejphar.2005.06.049. PubMed: 16125698.
64. Mikkelsen JD, Bundzikova J, Larsen MH, Hansen HH, Kiss A (2008) GABA regulates the rat hypothalamic-pituitary-adrenocortical axis via different GABA-A receptor alpha-subtypes. Ann N Y Acad Sci 1148: 384-392. doi:10.1196/annals.1410.044. PubMed: 19120132.
65. Castrén E, Rantamäki T (2010) The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol 70: 289-297. doi:10.1002/dneu.20758. PubMed: 20186711.
66. Sun Y, Evans J, Russell B, Kydd R, Connor B (2013) A benzodiazepine impairs the neurogenic and behavioural effects of fluoxetine in a rodent model of chronic stress. Neuropharmacology 72: 20-28. doi:10.1016/j.neuropharm.2013. 04.021. PubMed: 23639432.
67. Wu X, Castrén E (2009) Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells. Biol Psychiatry 66: 5-8. doi:10.1016/j.biopsych.2009.01.023. PubMed: 19251245.
68. Bosmann HB, Penney DP, Case KR, Averill K (1980) Diazepam receptor: specific nuclear binding of [3H]flunitrazepam. Proceedings of the National Academy of Sciences U S A 77: 1195-1198. doi:10.1073/pnas.77.2.1195.
69. Dalezios Y, Matsokis N (1993) Nuclear benzodiazepine binding: possible interaction with thyroid hormone receptors. Neurochem Res 18: 305-311. doi:10.1007/BF00969087. PubMed: 8479599.
70. Saha B, Mukherjee A, Santra CR, Chattopadhyay A, Ghosh AN et al. (2009) Alprazolam intercalates into DNA. J Biomol Struct Dyn 26: 421-429. doi:10.1080/07391102.2009.10507257. PubMed: 19108581.
71. Chung CW, Coste H, White JH, Mirguet O, Wilde J et al. (2011) Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J Med Chem 54: 3827-3838. doi:10.1021/jm200108t. PubMed: 21568322.
72. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB et al. (2010) Selective inhibition of BET bromodomains. Nature 468: 1067-1073. doi:10.1038/nature09504. PubMed: 20871596.
73. Kouzarides T (2007) Chromatin modifications and their function. Cell 128: 693-705. doi:10.1016/j.cell.2007.02.005. PubMed: 17320507.
74. Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY et al. (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52: 255-269. doi:10.1016/j. neuron.2006.09.037. PubMed: 17046689.
75. Baba A, Okumura S, Mizuo H, Iwata H (1983) The inhibition of diazepam and gamma-aminobutyric acid of depolarization-induced release of [14C]cysteine sulfinate and [ 3H]glutamate in rat hippocampal slices. J Neurochem 40: 280-284. doi:10.1111/j.1471-4159.1983.tb12683.x. PubMed: 6129289.
76. Fedele E, Ansaldo MA, Varnier G, Raiteri M (2000) Benzodiazepine- sensitive GABAA receptors limit the activity of the NMDA/NO/Cyclic GMP pathway: a microdialysis study in the cerebellum of freely moving rats. J Neurochem 75: 782-787. PubMed: 10899955.
77. Khan GM, Smolders I, Ebinger G, Michotte Y (2000) Flumazenil prevents diazepam-elicited anticonvulsant action and concomitant attenuation of glutamate overflow. Eur J Pharmacol 407: 139-144. doi:10.1016/S0014-2999(00)00720-2. PubMed: 11050301.
78. Morgan JI, Cohen DR, Hempstead JL, Curran T (1987) Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237: 192-197. doi:10.1126/science.3037702. PubMed: 3037702.
79. Moore AN, Waxham MN, Dash PK (1996) Neuronal activity increases the phosphorylation of the transcription factor cAMP response element-binding protein (CREB) in rat hippocampus and cortex. J Biol Chem 271: 14214-14220. doi:10.1074/jbc.271.24.14214. PubMed: 8662977.
80. Ichisaka S, Katoh-Semba R, Hata Y, Ohshima M, Kameyama K et al. (2003) Activity-dependent change in the protein level of brain-derived neurotrophic factor but no change in other neurotrophins in the visual cortex of young and adult ferrets. Neuroscience 117: 361-377. doi:10.1016/S0306-4522(02)00771-6. PubMed: 12614676.
81. Berninger B, Marty S, Zafra F, da Penha Berzaghi M, Thoenen H et al. (1995) GABAergic stimulation switches from enhancing to repressing BDNF expression in rat hippocampal neurons during maturation in vitro. Development 121: 2327-2335. PubMed: 7671799.
82. Raivio N, Tiraboschi E, Saarikoski ST, Castrén E, Kiianmaa K (2012) Brain-derived neurotrophic factor expression after acute administration of ethanol. Eur J Pharmacol 687: 9-13. doi:10.1016/j.ejphar.2012.04.021. PubMed: 22546227.